Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA)

  1. Schneeweiss, A.
  2. Chia, S.
  3. Hickish, T.
  4. Harvey, V.
  5. Eniu, A.
  6. Hegg, R.
  7. Tausch, C.
  8. Seo, J.H.
  9. Tsai, Y.-F.
  10. Ratnayake, J.
  11. McNally, V.
  12. Ross, G.
  13. Cortés, J.
Revista:
Annals of Oncology

ISSN: 0923-7534,  1569-8041

Ano de publicación: 2013

Volume: 24

Número: 9

Páxinas: 2278-2284

Tipo: Artigo

DOI: 10.1093/ANNONC/MDT182 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable

Fonte de datos: Scopus